PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany.\', \'German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.\', \'Munich Cluster of Systems Neurology (Synergy), Munich, Germany.\', \'bene pharmaChem GmbH & Co.KG., Geretsried, Germany.\', \'COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU Munich, Munich, Germany.\', \'Max von Pettenkofer Institute & Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.\', \'Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.\', \'Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.\', \'German Center for Infection Research (DZIF), partner site Munich, Germany.\', \'Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany.\', \'Institute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany.\', \'Core facility Bioinformatics, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/jev2.12173
?:doi
?:hasPublicationType
?:journal
  • Journal of extracellular vesicles
is ?:pmid of
?:pmid
?:pmid
  • 34854246
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.973
?:rankingScore_hIndex
  • 37
is ?:relation_isRelatedTo_publication of
?:title
  • Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all